Turner, David C.
Merck & Co., Inc., Rahway, NJ, USA (United States)
2 papers on CoChatORCID 0000-0001-9242-6188
Most cited papers
- Verified
Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells
Vilgelm, A. E., Pawlikowski, J. S., Liu, Y., Hawkins, O. E., Davis, T. A., Smith, J., Weller, K. P., Horton, L. W., McClain, C. M., Ayers, G. D., et al. (2015) · Cancer Research
Cancer-related Molecular PathwaysTelomeres, Telomerase, and Senescence
Cited by 115
- Verified
Immunogenicity of pembrolizumab in patients with advanced tumors
van Vugt, M. J. H., Stone, J. A., De Greef, “. H. J. M. M., Snyder, E. S., Lipka, L., Turner, D. C., Chain, A., Lala, M., Li, M., Robey, S. H., et al. (2019) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersBiosimilars and Bioanalytical Methods
Cited by 57
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free